How Intermittent Fasting Protects Joints by Reducing Neuropeptide Y
Intermittent fasting relieved osteoarthritis in mice by reducing excess neuropeptide Y secretion from bone cells, which was driving joint inflammation.
Quick Facts
What This Study Found
Osteocytes (the most common bone cells) secreted excess neuropeptide Y during osteoarthritis. This NPY promoted inflammation, osteoclast formation (cells that break down bone), and neurite outgrowth (nerve growth that contributes to pain).
Intermittent fasting reversed these effects. Culture medium from osteocytes of fasting mice did not trigger the same inflammatory and bone-destroying responses. When researchers genetically deleted NPY from osteocytes, intermittent fasting lost its beneficial effects on osteoarthritis. This proved that osteocyte NPY is the specific target through which fasting works.
The findings held in both surgically induced osteoarthritis (meniscus destabilization) and natural aging-induced osteoarthritis.
Key Numbers
- Excess NPY secreted by osteocytes during osteoarthritis
- NPY promoted pro-inflammatory, pro-osteoclastic, and pro-neurite outgrowth effects
- Intermittent fasting reversed these effects
- Osteocyte NPY knockout abolished fasting benefits
- Effective in both surgical (DMM) and aging-induced OA models
How They Did This
Researchers used two mouse osteoarthritis models: surgically induced (destabilization of the medial meniscus, DMM) and natural aging. They tested intermittent fasting in both models. They measured NPY levels, inflammation markers, osteoclast formation, and nerve outgrowth. They used osteocyte-specific NPY knockout mice to confirm the mechanism. Cell culture experiments with osteocyte-conditioned medium tested the direct effects of NPY.
Why This Research Matters
Osteoarthritis affects over 500 million people worldwide with no disease-modifying treatment. Intermittent fasting has shown health benefits in many contexts, but the mechanism for joint protection was unknown. This study identifies a specific molecular pathway: osteocyte NPY. This could lead to targeted drug development for osteoarthritis.
The Bigger Picture
Osteoarthritis affects over 500 million people with no disease-modifying treatment. This discovery of the NPY-osteocyte connection provides a new therapeutic target and a mechanistic explanation for why intermittent fasting may help joint health.
What This Study Doesn't Tell Us
This was tested in mice, not people. Mouse osteoarthritis models do not perfectly replicate the decades-long progression of human osteoarthritis. The specific intermittent fasting protocol may not translate directly to human practice. The osteocyte NPY knockout was a genetic deletion, not a drug intervention. Whether blocking NPY pharmacologically would have the same effect is unknown.
Questions This Raises
- ?Would NPY-blocking drugs replicate the fasting benefit without dietary changes?
- ?Does this mechanism operate in human osteoarthritis?
Trust & Context
- Key Stat:
- New mechanism discovered Osteocyte-derived neuropeptide Y was identified for the first time as a driver of osteoarthritis inflammation, bone destruction, and nerve growth
- Evidence Grade:
- Rated preliminary: strong mechanistic animal study using both surgical and aging models plus genetic confirmation, but entirely in mice.
- Study Age:
- Published in 2024. This is a new mechanistic discovery linking NPY, bone cells, and osteoarthritis.
- Original Title:
- Intermittent Fasting Targets Osteocyte Neuropeptide Y to Relieve Osteoarthritis.
- Published In:
- Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11(34), e2400196 (2024)
- Authors:
- Qian, Yu-Xuan, Rao, Shan-Shan, Tan, Yi-Juan, Wang, Zun, Yin, Hao, Wan, Teng-Fei, He, Ze-Hui, Wang, Xin, Hong, Chun-Gu, Zeng, Hai-Jin, Luo, Yi, Duan, Yan-Xin, Zhu, Hao, Hu, Xin-Yue, Zou, Ling, Zhang, Yan, Liu, Bing-Bing, Wang, Zhen-Xing, Du, Wei, Chen, Chun-Yuan, Xie, Hui
- Database ID:
- RPEP-09103
Evidence Hierarchy
Frequently Asked Questions
Can intermittent fasting help osteoarthritis?
In mice, it significantly improved joint health by reducing neuropeptide Y from bone cells. Human studies are needed to confirm the same mechanism works in people.
What is neuropeptide Y's role in osteoarthritis?
Bone cells release excess NPY during osteoarthritis, which promotes inflammation, attracts bone-destroying cells, and stimulates nerve growth in joints — worsening pain and damage.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09103APA
Qian, Yu-Xuan; Rao, Shan-Shan; Tan, Yi-Juan; Wang, Zun; Yin, Hao; Wan, Teng-Fei; He, Ze-Hui; Wang, Xin; Hong, Chun-Gu; Zeng, Hai-Jin; Luo, Yi; Duan, Yan-Xin; Zhu, Hao; Hu, Xin-Yue; Zou, Ling; Zhang, Yan; Liu, Bing-Bing; Wang, Zhen-Xing; Du, Wei; Chen, Chun-Yuan; Xie, Hui. (2024). Intermittent Fasting Targets Osteocyte Neuropeptide Y to Relieve Osteoarthritis.. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11(34), e2400196. https://doi.org/10.1002/advs.202400196
MLA
Qian, Yu-Xuan, et al. "Intermittent Fasting Targets Osteocyte Neuropeptide Y to Relieve Osteoarthritis.." Advanced science (Weinheim, 2024. https://doi.org/10.1002/advs.202400196
RethinkPeptides
RethinkPeptides Research Database. "Intermittent Fasting Targets Osteocyte Neuropeptide Y to Rel..." RPEP-09103. Retrieved from https://rethinkpeptides.com/research/qian-2024-intermittent-fasting-targets-osteocyte
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.